Rankings
▼
Calendar
ZYME Q2 2021 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-85.7% YoY
Gross Profit
-$49M
-2763.4% margin
Operating Income
-$69M
-3889.6% margin
Net Income
-$68M
-3812.6% margin
EPS (Diluted)
$-1.31
QoQ Revenue Growth
+175.0%
Cash Flow
Operating Cash Flow
-$50M
Free Cash Flow
-$52M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$472M
Total Liabilities
$150M
Stockholders' Equity
$321M
Cash & Equivalents
$257M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$12M
-85.7%
Gross Profit
-$49M
-$27M
-82.2%
Operating Income
-$69M
-$40M
-70.7%
Net Income
-$68M
-$39M
-73.3%
Revenue Segments
Other Product
$2M
100%
← FY 2021
All Quarters
Q3 2021 →